USDL returns to profitability
Executives at imaging center chain U.S. Diagnostic believe the firm is back on track following three straight quarters of losses. The West Palm Beach, FL-based firm posted a 6% increase in revenue and a net profit during its first quarter.For the period
Executives at imaging center chain U.S. Diagnostic believe the firm is back on track following three straight quarters of losses. The West Palm Beach, FL-based firm posted a 6% increase in revenue and a net profit during its first quarter.
For the period (end-March), sales were $54.5 million, compared with $51.4 million reported in the same period last year. Net income was $746,000, compared with $2 million in 1997.
President and CEO Joseph Paul expects progressive improvement in the companys financial results through 1998. In the first of its four-step corporate growth strategy, USDL initiated a cost-cutting and efficiency effort towards the end of the first quarter. The impact of most of the cost-cutting will be realized in the second quarter and beyond.
In the second part of the strategy, USDL is divesting noncore assets, such as its mobile subsidiary Medical Diagnostics, and focusing on its core business of fixed-site imaging centers. The sale of MDI to Alliance Imaging closed this month.
USDL is also making progress in refinancing its debt. Upon completion of this third objective, the company believes that additional funds will be available for the final strategic goal, which is to resume acquisitions to complement the firms imaging networks.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
